| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation.
|
Blood
|
2005
|
2.44
|
|
2
|
Long-term follow-up of haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of leukemia: nine years of experience at a single center.
|
Cancer
|
2012
|
1.65
|
|
3
|
Risk stratification-directed donor lymphocyte infusion could reduce relapse of standard-risk acute leukemia patients after allogeneic hematopoietic stem cell transplantation.
|
Blood
|
2012
|
1.61
|
|
4
|
Early lymphocyte recovery predicts superior overall survival after unmanipulated haploidentical blood and marrow transplant for myelodysplastic syndrome and acute myeloid leukemia evolving from myelodysplastic syndrome.
|
Leuk Lymphoma
|
2013
|
1.46
|
|
5
|
Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
|
Biol Blood Marrow Transplant
|
2009
|
1.45
|
|
6
|
The superiority of haploidentical related stem cell transplantation over chemotherapy alone as postremission treatment for patients with intermediate- or high-risk acute myeloid leukemia in first complete remission.
|
Blood
|
2012
|
1.25
|
|
7
|
MRD-directed risk stratification treatment may improve outcomes of t(8;21) AML in the first complete remission: results from the AML05 multicenter trial.
|
Blood
|
2013
|
1.21
|
|
8
|
Association of an impaired bone marrow microenvironment with secondary poor graft function after allogeneic hematopoietic stem cell transplantation.
|
Biol Blood Marrow Transplant
|
2013
|
1.17
|
|
9
|
Bis(dimethyl-ammonium) 2,2'-(1,3,6,8-tetra-oxo-2,7-diaza-pyrene-2,7-di-yl)diacetate.
|
Acta Crystallogr Sect E Struct Rep Online
|
2011
|
1.15
|
|
10
|
Superior graft-versus-leukemia effect associated with transplantation of haploidentical compared with HLA-identical sibling donor grafts for high-risk acute leukemia: an historic comparison.
|
Biol Blood Marrow Transplant
|
2010
|
1.12
|
|
11
|
Donor lymphocyte infusion for the treatment of leukemia relapse after HLA-mismatched/haploidentical T-cell-replete hematopoietic stem cell transplantation.
|
Haematologica
|
2007
|
1.09
|
|
12
|
Modified donor lymphocyte infusion (DLI) for the prophylaxis of leukemia relapse after hematopoietic stem cell transplantation in patients with advanced leukemia--feasibility and safety study.
|
J Clin Immunol
|
2008
|
1.03
|
|
13
|
Immune reconstitution following unmanipulated HLA-mismatched/haploidentical transplantation compared with HLA-identical sibling transplantation.
|
J Clin Immunol
|
2011
|
1.03
|
|
14
|
Imatinib mesylate versus allogeneic hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia in the accelerated phase.
|
Blood
|
2011
|
1.00
|
|
15
|
The effect of HLA disparity on clinical outcome after HLA-haploidentical blood and marrow transplantation.
|
Clin Transplant
|
2011
|
0.99
|
|
16
|
In adults with t(8;21)AML, posttransplant RUNX1/RUNX1T1-based MRD monitoring, rather than c-KIT mutations, allows further risk stratification.
|
Blood
|
2014
|
0.93
|
|
17
|
The hematopoietic cell transplantation-specific comorbidity index (HCT-CI) is an outcome predictor for partially matched related donor transplantation.
|
Am J Hematol
|
2013
|
0.92
|
|
18
|
Modified donor lymphocyte infusion-associated acute graft-versus-host disease after haploidentical T-cell-replete hematopoietic stem cell transplantation: incidence and risk factors.
|
Clin Transplant
|
2012
|
0.90
|
|
19
|
Protective immunity transferred by infusion of cytomegalovirus-specific CD8(+) T cells within donor grafts: its associations with cytomegalovirus reactivation following unmanipulated allogeneic hematopoietic stem cell transplantation.
|
Biol Blood Marrow Transplant
|
2010
|
0.90
|
|
20
|
Monitoring MRD with flow cytometry: an effective method to predict relapse for ALL patients after allogeneic hematopoietic stem cell transplantation.
|
Ann Hematol
|
2011
|
0.90
|
|
21
|
High frequency of CD4+ CD25- CD69+ T cells is correlated with a low risk of acute graft-versus-host disease in allotransplants.
|
Clin Transplant
|
2012
|
0.89
|
|
22
|
Platelet engraftment in patients with hematologic malignancies following unmanipulated haploidentical blood and marrow transplantation: effects of CD34+ cell dose and disease status.
|
Biol Blood Marrow Transplant
|
2009
|
0.88
|
|
23
|
Modified donor lymphocyte infusion after HLA-mismatched/haploidentical T cell-replete hematopoietic stem cell transplantation for prophylaxis of relapse of leukemia in patients with advanced leukemia.
|
J Clin Immunol
|
2008
|
0.87
|
|
24
|
Administration of imatinib in the first 90 days after allogeneic hematopoietic cell transplantation in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
|
Chin Med J (Engl)
|
2011
|
0.86
|
|
25
|
Chemotherapy followed by modified donor lymphocyte infusion as a treatment for relapsed acute leukemia after haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion: superior outcomes compared with chemotherapy alone and an analysis of prognostic factors.
|
Eur J Haematol
|
2013
|
0.86
|
|
26
|
Prognosis after unmanipulated HLA-haploidentical blood and marrow transplantation is correlated to the numbers of KIR ligands in recipients.
|
Eur J Haematol
|
2007
|
0.84
|
|
27
|
Prevention of relapse using DLI can increase survival following HLA-identical transplantation in patients with advanced-stage acute leukemia: a multi-center study.
|
Clin Transplant
|
2012
|
0.83
|
|
28
|
Impact of pretransplantation risk factors on post transplantation outcome of patients with acute myeloid leukemia in remission after haploidentical hematopoietic stem cell transplantation.
|
Biol Blood Marrow Transplant
|
2012
|
0.83
|
|
29
|
Influence of lymphocyte recovery on outcome of haploidentical transplantation for hematologic malignancies.
|
Medicine (Baltimore)
|
2009
|
0.83
|
|
30
|
Reconstitution of natural killer cell receptor repertoires after unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation: analyses of CD94:NKG2A and killer immunoglobulin-like receptor expression and their associations with clinical outcome.
|
Biol Blood Marrow Transplant
|
2007
|
0.82
|
|
31
|
Doubly interpenetrated chiral (10,3)-a network with charge-transfer-type guest inclusion.
|
Inorg Chem
|
2013
|
0.81
|
|
32
|
Quantitative chimerism kinetics in relapsed leukemia patients after allogeneic hematopoietic stem cell transplantation.
|
Chin Med J (Engl)
|
2012
|
0.81
|
|
33
|
Haploidentical/mismatched hematopoietic stem cell transplantation without in vitro T cell depletion for T cell acute lymphoblastic leukemia.
|
Biol Blood Marrow Transplant
|
2011
|
0.81
|
|
34
|
Clinical impact of absolute lymphocyte count on day 30 after unmanipulated haploidentical blood and marrow transplantation for pediatric patients with hematological malignancies.
|
Am J Hematol
|
2011
|
0.81
|
|
35
|
Haploidentical hematopoietic stem cell transplantation in adults with Philadelphia-negative acute lymphoblastic leukemia: no difference in the high- and low-risk groups.
|
Int J Cancer
|
2014
|
0.81
|
|
36
|
PRAME and WT1 transcripts constitute a good molecular marker combination for monitoring minimal residual disease in myelodysplastic syndromes.
|
Leuk Lymphoma
|
2012
|
0.80
|
|
37
|
[The efficacy and safety of mismatched hematopoietic stem cell transplantation for treatment of severe aplastic anemia].
|
Zhonghua Nei Ke Za Zhi
|
2011
|
0.80
|
|
38
|
Combined transplantation of G-CSF primed allogeneic bone marrow cells and peripheral blood stem cells in treatment of severe aplastic anemia.
|
Chin Med J (Engl)
|
2004
|
0.80
|
|
39
|
A chiral interdigitated supramolecular network assembled from single-stranded helical tubes.
|
Acta Crystallogr C
|
2011
|
0.80
|
|
40
|
Individualized intervention guided by BCR-ABL transcript levels after HLA-identical sibling donor transplantation improves HSCT outcomes for patients with chronic myeloid leukemia.
|
Biol Blood Marrow Transplant
|
2010
|
0.79
|
|
41
|
Monocytic and promyelocytic myeloid-derived suppressor cells may contribute to G-CSF-induced immune tolerance in haplo-identical allogeneic hematopoietic stem cell transplantation.
|
Am J Hematol
|
2015
|
0.79
|
|
42
|
Idiopathic inflammatory demyelinating diseases of the central nervous system in patients following allogeneic hematopoietic stem cell transplantation: a retrospective analysis of incidence, risk factors and survival.
|
Chin Med J (Engl)
|
2013
|
0.79
|
|
43
|
Nonmalignant late effects in survivors of partially matched donor hematopoietic stem cell transplantation.
|
Biol Blood Marrow Transplant
|
2013
|
0.78
|
|
44
|
The impact of graft composition on clinical outcomes in pediatric patients undergoing unmanipulated HLA-mismatched/haploidentical hematopoietic stem cell transplantation.
|
Pediatr Blood Cancer
|
2011
|
0.78
|
|
45
|
The incidence, risk factors, and outcomes of primary poor graft function after unmanipulated haploidentical stem cell transplantation.
|
Ann Hematol
|
2015
|
0.78
|
|
46
|
The impact of CD34+ cell dose on platelet engraftment in pediatric patients following unmanipulated haploidentical blood and marrow transplantation.
|
Pediatr Blood Cancer
|
2009
|
0.78
|
|
47
|
High-dose cyclophosphamide therapy associated with diffuse alveolar hemorrhage after allogeneic hematopoietic stem cell transplantation.
|
Respiration
|
2012
|
0.78
|
|
48
|
[The risk factors and prognosis of transplant-associated thrombotic microangiopathy following acute graft-versus-host disease].
|
Zhonghua Nei Ke Za Zhi
|
2013
|
0.77
|
|
49
|
[The efficacy and safety of second allogeneic hematopoietic stem cell transplantation for post-transplant hematologic malignancies relapse].
|
Zhonghua Nei Ke Za Zhi
|
2011
|
0.77
|
|
50
|
Safety of recombinant human thrombopoietin in adults after related donor haploidentical haematopoietic stem cell transplantation: a pilot study.
|
Clin Drug Investig
|
2011
|
0.77
|
|
51
|
Improved outcome with hematopoietic stem cell transplantation in a poor prognostic subgroup of patients with mixed-lineage-leukemia-rearranged acute leukemia: Results from a prospective, multi-center study.
|
Am J Hematol
|
2014
|
0.77
|
|
52
|
Potential immunosuppressive function of plasma indoleamine 2,3-dioxygenase in patients with aGVHD after allo-HSCT.
|
Clin Transplant
|
2011
|
0.76
|
|
53
|
The cell composition of infused donor lymphocyte has different impact in different types of allogeneic hematopoietic stem cell transplantation.
|
Clin Transplant
|
2014
|
0.76
|
|
54
|
Characteristics and influencing factors of CD19+ B cell reconstitution in patients following haploidentical/mismatched hematopoietic stem cell transplantation.
|
Int J Hematol
|
2012
|
0.76
|
|
55
|
[A clinical study of allo-hematopoietic stem cell transplantation in HBsAg positive leukemia].
|
Zhonghua Nei Ke Za Zhi
|
2008
|
0.76
|
|
56
|
Recruitment of CD8(+) T cells into bone marrow might explain the suppression of megakaryocyte apoptosis through high expression of CX3CR1(+) in prolonged isolated thrombocytopenia after allogeneic hematopoietic stem cell transplantation.
|
Ann Hematol
|
2015
|
0.76
|
|
57
|
Monitoring the source of mesenchymal stem cells in patients after transplantation of mismatched-sex hematopoietic stem cells plus third-party cells.
|
Chin Med J (Engl)
|
2013
|
0.76
|
|
58
|
catena-Poly[[[tetra-aqua-copper(II)]-μ-4,4'-bipyridyl-κ(2)N:N'] tetra-fluorido-succinate tetra-hydrate].
|
Acta Crystallogr Sect E Struct Rep Online
|
2012
|
0.75
|
|
59
|
Heart failure after allogeneic hematopoietic stem cell transplantation.
|
Int J Cardiol
|
2012
|
0.75
|
|
60
|
Cytomegalovirus is a potential risk factor for late-onset hemorrhagic cystitis following allogeneic hematopoietic stem cell transplantation.
|
Am J Hematol
|
2013
|
0.75
|
|
61
|
4,4'-Bipyrid-yl-4,4'-(hy-droxy-methyl-ene)dibenzoic acid (1/1).
|
Acta Crystallogr Sect E Struct Rep Online
|
2012
|
0.75
|
|
62
|
Bis(dimethyl-ammonium) 3,3'-dicarb-oxy-5,5'-(5,7,12,14-tetra-oxo-6,13-diaza-tetra-cyclo-[6.6.2.0(4,16).0(11,15)]hexa-deca-1,3,8,10,15-penta-ene-6,13-di-yl)dibenzoate dihydrate.
|
Acta Crystallogr Sect E Struct Rep Online
|
2012
|
0.75
|
|
63
|
[Analysis of etiology of hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation].
|
Zhonghua Yi Xue Za Zhi
|
2007
|
0.75
|
|
64
|
[Analysis of risk factors for the development of hemorrhagic cystitis post allogeneic hematopoietic stem cell transplantation].
|
Zhonghua Xue Ye Xue Za Zhi
|
2007
|
0.75
|
|
65
|
[Clinical characteristics of acute graft-versus-host disease among different donors of allogeneic hematopoietic stem cell transplantation].
|
Zhonghua Xue Ye Xue Za Zhi
|
2010
|
0.75
|
|
66
|
[The prognostic analysis of KIR ligand mismatch in HLA-mismatched hematopoietic stem cell transplantation].
|
Zhonghua Xue Ye Xue Za Zhi
|
2008
|
0.75
|
|
67
|
[Donor lymphocyte infusion for treatment of relapse of leukemia after HLA-mismatched hematopoietic stem cell transplantation].
|
Zhonghua Xue Ye Xue Za Zhi
|
2008
|
0.75
|
|
68
|
[A clinical analysis of HLA-identical hematopoietic stem cell transplantation for severe aplastic anemia.].
|
Zhonghua Nei Ke Za Zhi
|
2009
|
0.75
|
|
69
|
[The value of serum galactomannan detection for diagnosis of invasive aspergillosis in hematopoietic stem cell transplant recipients].
|
Zhonghua Xue Ye Xue Za Zhi
|
2007
|
0.75
|
|
70
|
Higher proportions of peripheral CD19+CD5+ B cells predict the effect of corticosteroid in patients with late-onset hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation.
|
Chin Med J (Engl)
|
2011
|
0.75
|
|
71
|
[Pharmacokinetics of antithymocyte globulin in recipients under-going HLA partially matched hematopoietic stem cell transplantation].
|
Zhongguo Shi Yan Xue Ye Xue Za Zhi
|
2007
|
0.75
|
|
72
|
[Mycophenolate mofetil in treatment of graft-versus-host disease after allogeneic hematopoietic cell transplantation: analysis of 44 cases].
|
Zhonghua Yi Xue Za Zhi
|
2008
|
0.75
|
|
73
|
[Relationship between copies of cytomegalovirus in plasma and cytomegalovirus disease after allogeneic hematopoietic stem cell transplantation].
|
Zhonghua Yi Xue Za Zhi
|
2009
|
0.75
|
|
74
|
[Factors influencing engraftment in hematological patients after human leukocyte antigen matched sibling allogeneic blood and marrow transplantation].
|
Zhonghua Nei Ke Za Zhi
|
2009
|
0.75
|
|
75
|
[Multiple factors in erythrocytic recovery following ABO-incompatible allogeneic HSCT].
|
Zhongguo Shi Yan Xue Ye Xue Za Zhi
|
2004
|
0.75
|
|
76
|
[Clinical study on the relapsd leukemia patients with graft versus host disease after allogeneic hematopoietic stem cell transplantation].
|
Zhonghua Xue Ye Xue Za Zhi
|
2010
|
0.75
|
|
77
|
[Correlation between the change in liver enzymology and the severity of acute graft-versus-host disease.].
|
Zhonghua Xue Ye Xue Za Zhi
|
2009
|
0.75
|
|
78
|
[Comparison study on treatment of acute graft-versus-host disease with low-dose methotrexate in combination with low-dose methylprednisolone or standard-dose methylprednisolone].
|
Zhonghua Xue Ye Xue Za Zhi
|
2011
|
0.75
|
|
79
|
[The significance of dynamic detection of WT1 expression on patients of hematologic malignancy following allogeneic hematopoietic stem cell transplantation].
|
Zhonghua Nei Ke Za Zhi
|
2008
|
0.75
|
|
80
|
[Etiological analysis of fever in the first 24 hours following allogeneic peripheral stem cell transfusion].
|
Zhonghua Nei Ke Za Zhi
|
2012
|
0.75
|
|
81
|
[Unexplained multiple effusions as a manifestation of chronic graft-versus-host disease after allogeneic hematopoietic transplantation.].
|
Zhonghua Xue Ye Xue Za Zhi
|
2010
|
0.75
|
|
82
|
[Application of ricin-immunotoxin mediated T cell depletion to allogeneic hematopoietic stem cell transplantation].
|
Zhongguo Shi Yan Xue Ye Xue Za Zhi
|
2004
|
0.75
|
|
83
|
[Monitoring AML1-ETO mRNA levels by real-time quantitative RT-PCR in t(8;21) acute myeloid leukemia patients after hematopoietic stem cell transplantation].
|
Zhonghua Xue Ye Xue Za Zhi
|
2008
|
0.75
|
|
84
|
[Safety comparison of mobilization and collection of hematopoietic stem cells between related and unrelated donors].
|
Zhongguo Shi Yan Xue Ye Xue Za Zhi
|
2010
|
0.75
|
|
85
|
[A comparative study of the curative effects of cytomegalovirus preemptive therapy in various kinds of hematopoietic stem-cell transplantation].
|
Zhonghua Nei Ke Za Zhi
|
2009
|
0.75
|
|
86
|
[Randomized clinical study for two types of recombinant human granulocyte colony-stimulating factor mobilizing peripheral blood and bone marrow stem cells in patients receiving allogeneic hematopoietic stem cell transplantation].
|
Zhonghua Yi Xue Za Zhi
|
2009
|
0.75
|